Analyzing Fidelity National Information Services (NYSE:FIS) & KindlyMD (NASDAQ:NAKA)

Fidelity National Information Services (NYSE:FIS) and KindlyMD (NASDAQ:NAKA) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for Fidelity National Information Services and KindlyMD, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fidelity National Information Services	2	11	11	0	2.38
KindlyMD	1	0	3	0	2.50

Fidelity National Information Services currently has a consensus target price of $49.04, indicating a potential upside of 30.65%. KindlyMD has a consensus target price of $20.00, indicating a potential upside of 171.74%. Given KindlyMD’s stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Fidelity National Information Services.

Earnings & Valuation

This table compares Fidelity National Information Services and KindlyMD”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fidelity National Information Services	$10.68 billion	1.82	$382.00 million	$6.51	5.77
KindlyMD	$39.89 million	3.39	-$52.23 million	($35.85)	-0.21

Fidelity National Information Services has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Fidelity National Information Services, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

96.2% of Fidelity National Information Services shares are held by institutional investors. 0.3% of Fidelity National Information Services shares are held by company insiders. Comparatively, 24.5% of KindlyMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Fidelity National Information Services and KindlyMD’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fidelity National Information Services	27.64%	20.95%	8.13%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Risk and Volatility

Fidelity National Information Services has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, KindlyMD has a beta of 15.82, meaning that its stock price is 1,482% more volatile than the S&P 500.

Summary

Fidelity National Information Services beats KindlyMD on 9 of the 14 factors compared between the two stocks.

About Fidelity National Information Services

Fidelity National Information Services, Inc. engages in the provision of financial services technology solutions for financial institutions, businesses, and developers worldwide. It operates through Banking Solutions, Capital Market Solutions, and Corporate and Other segments. The company provides core processing and ancillary applications; mobile and online banking; fraud, risk management, and compliance; card and retail payment; electronic funds transfer and network; wealth and retirement; and item processing and output solutions. It also offers trading and asset, lending, leveraged and syndicated loan markets, and treasury and risk solutions. The company was founded in 1968 and is headquartered in Jacksonville, Florida.

About KindlyMD

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.